Glucose-lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes.
Ponirakis G, Al-Janahi I, Elgassim E, Hussein R, Petropoulos IN, Gad H, Khan A, Zaghloul HB, Siddique MA, Ali H, Mohamed FFS, Ahmed LHM, Dakroury Y, El Shewehy AMM, Saeid R, Mahjoub F, Al-Thani SN, Ahmed F, Homssi M, Mahmoud S, Hadid NH, Obaidan AA, Salivon I, Mahfoud ZR, Zirie MA, Al-Ansari Y, Atkin SL, Malik RA.
Ponirakis G, et al. Among authors: petropoulos in.
J Peripher Nerv Syst. 2024 Dec;29(4):406-414. doi: 10.1111/jns.12664. Epub 2024 Oct 22.
J Peripher Nerv Syst. 2024.
PMID: 39439079
Free PMC article.